https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 What is the “optimal” target mismatch criteria for acute ischemic stroke? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43675 P = 0.005), whereas there was no such association between reperfusion and an excellent outcome with any of the CCM criteria (all p > 0.05). Notably, in IVT-LVO cohort, 58.2% of the PIM-DT positive patients achieved an excellent outcome compared with 31.0% in non-mismatch patients following successful recanalization (P = 0.006).]]> Wed 28 Sep 2022 14:35:18 AEST ]]> Poor collateral flow with severe hypoperfusion explains worse outcome in acute stroke patients with atrial fibrillation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52831 Wed 28 Feb 2024 16:31:25 AEDT ]]> Endovascular thrombectomy: tirofiban increases bleeding risk in acute stroke patients https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44530 Wed 09 Nov 2022 10:25:52 AEDT ]]> Association of collateral status and ischemic core growth in patients with acute ischemic stroke https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41051 p < 0.001). The relationship of core growth and CTP collateral index was validated in cohort 2. An increment in collateral index by 1% resulted in an increase of core growth by 0.59 mL/h (coefficient 0.59 [0.48–0.71], p < 0.001) in cohort 2. Conclusion: Collateral status is a major determinant of ischemic core growth.]]> Mon 08 Aug 2022 14:50:17 AEST ]]> Intraarterial Versus Intravenous Tirofiban as an Adjunct to Endovascular Thrombectomy for Acute Ischemic Stroke https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41585 Fri 05 Aug 2022 14:51:26 AEST ]]>